Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00PVO
|
||||
| Former ID |
DNC011360
|
||||
| Drug Name |
GNF-PF-3464
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531262] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H16BrN3O2S
|
||||
| Canonical SMILES |
CC1=CC=C(O1)C2CC(=O)N3CN(CSC3=C2C#N)C4=CC=C(C=C4)Br
|
||||
| InChI |
1S/C19H16BrN3O2S/c1-12-2-7-17(25-12)15-8-18(24)23-10-22(11-26-19(23)16(15)9-21)14-5-3-13(20)4-6-14/h2-7,15H,8,10-11H2,1H3
|
||||
| InChIKey |
DCNZODDMKOTPHQ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Nonstructural protein NS3 | Target Info | Inhibitor | [531262] | |
| Voltage-dependent N-type calcium channel | Target Info | Inhibitor | [531262] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
| Ionotropic glutamate receptor pathway | |||||
| Metabotropic glutamate receptor group III pathway | |||||
| Metabotropic glutamate receptor group II pathway | |||||
| Thyrotropin-releasing hormone receptor signaling pathway | |||||
| Endogenous cannabinoid signaling | |||||
| GABA-B receptor II signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.